Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
. Candidates will perform research on agentic AI, foundational modeling, optimization, and control of multiagent autonomous systems with an application in renewable energy and power grids, in addition to working
-
code comments and appropriate documentation to various knowledge-based system(s) to simplify code maintenance and to improve the support. Testing & Documentation Create and document test scenarios using
-
, AI system engineering, software product development, technology management, digital transformation, business applications of (generative or agentic) AI, software analytics, or AI for software
-
platform – creation of a domain-specific, constrained Large Language Model (LLM) and AI agents for use within an OMS; Model development and training; Integration of AI agents. Applicable legislation and
-
fungal infections. Emerging research is exploring radiometals conjugated with targeting molecules for in vivo imaging of infections via PET or SPECT. These agents can also be linked to therapeutics
-
applications. This project key innovation lies in incorporating novel antivirulence compounds (agents that target bacterial quorum sensing rather than viability) into these scaffolds. By inhibiting pathogenic
-
fungal infections. Emerging research is exploring radiometals conjugated with targeting molecules for in vivo imaging of infections via PET or SPECT. These agents can also be linked to therapeutics
-
, linked to a radioisotope emitting ionizing radiation. During their preclinical development phase, these therapeutic agents are administered to tumor-bearing rodents undergoing longitudinal small-animal
-
fungal infections. Emerging research is exploring radiometals conjugated with targeting molecules for in vivo imaging of infections via PET or SPECT. These agents can also be linked to therapeutics
-
individual synovial membrane and osteochondral unit-on-chip models as well as a their combination in the joint-on-chip to test established and new disease modifying agents to validate their use in drug